The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...
She had worsening anemia, but thrombotic thrombocytopenic purpura was ruled out, as there was no conclusive evidence of microangiopathic hemolytic anemia. CT of the brain revealed multiple ...
Four cases of Coombs-positive hemolytic anemia have been described in which the administration of penicillin to patients with circulating antipenicillin antibody was the suspected cause of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback